Skip to content

Advertisement

Open Peer Review Reports for: Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
6 Jan 2013 Submitted Original manuscript
11 Feb 2013 Author responded Author comments - Chiara Zecca
Resubmission - Version 2
11 Feb 2013 Submitted Manuscript version 2
24 Jun 2013 Reviewed Reviewer Report - Douglas Jeffery
1 Jul 2013 Reviewed Reviewer Report - Dana Horakova
6 Jul 2013 Reviewed Reviewer Report - Ondrej Dolezal
11 Jul 2013 Author responded Author comments - Chiara Zecca
Resubmission - Version 3
11 Jul 2013 Submitted Manuscript version 3
27 Jul 2013 Reviewed Reviewer Report - Ondrej Dolezal
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Jul 2013 Editorially accepted
2 Aug 2013 Article published 10.1186/1471-2377-13-101

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement